M JAMES BARRETT Insider Trading Transactions
Get free email notifications about insider trading for M JAMES BARRETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of M JAMES BARRETT. M JAMES BARRETT is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and Director in PHARMION CORP ($PHRM) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Liquidia Technologies Inc ($LQDA) and Director in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Epizyme, Inc. ($EPZM) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Zosano Pharma Corp ($ZSAN) and Director in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Surface Oncology, Inc. ($SURF).
Latest Insider Trading Transactions of M JAMES BARRETT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, ARDM, ARDX, CRCM, CBIO, CERC, CLVS, EPZM, GLYC, HPTX, INHX, INWK, IOMI, ILIU, LIQDA, LOXO, MRSN, MULE, MYOG, PRTK, PHRM, RARX, RYTM, SENS, ROKA, SUPN, SURF, SYBX, TSRO, TCON, VTAE, VG, YMTX, ZSAN, ZHNE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2019 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Option Exercise | A | 1.97 | 86,930 | 171,252 | 86,930 | |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | BARRETT M JAMES | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
Oct 03 2018 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Grant | A | 4.54 | 2,147 | 9,747 | 509,096 | 506.9 K to 509.1 K (+0.42 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Option Exercise | J | 0.01 | 40,702 | 407 | 40,702 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Option Exercise | J | 0.01 | 684,911 | 6,849 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 16,502,833 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 3,337,206 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 3,645,307 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Buy | P | 11.00 | 545,455 | 6,000,005 | 2,484,870 | 1.9 M to 2.5 M (+28.12 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 980,715 | 0 | 1,939,415 | 958.7 K to 1.9 M (+102.30 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 432,033 | 0 | 958,700 | 526.7 K to 958.7 K (+82.03 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 515,547 | 0 | 526,667 | 11.1 K to 526.7 K (+4,636.21 %) |
Jul 05 2018 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Grant | A | 4.43 | 2,200 | 9,746 | 506,949 | 504.7 K to 506.9 K (+0.44 %) |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
May 30 2018 | ARDX | ARDELYX, INC. | BARRETT M JAMES | 10% Owner | Grant | A | 4.00 | 416,667 | 1,666,668 | 9,169,210 | 8.8 M to 9.2 M (+4.76 %) |
May 21 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | A | 18.41 | 11,000 | 202,510 | 11,000 | |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | X | 0.33 | 298,406 | 98,474 | 0 | |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | X | 0.33 | 216,046 | 71,295 | 0 | |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Sell | S | 17.81 | 5,533 | 98,543 | 4,995,664 | 5 M to 5 M (-0.11 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | X | 0.33 | 298,406 | 98,474 | 5,001,197 | 4.7 M to 5 M (+6.35 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Sell | S | 17.81 | 4,006 | 71,347 | 4,702,791 | 4.7 M to 4.7 M (-0.09 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | X | 0.33 | 216,046 | 71,295 | 4,706,797 | 4.5 M to 4.7 M (+4.81 %) |
May 09 2018 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 12,679,970 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Sell | U | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 12,679,970 | 0 | 12,679,970 | 0 to 12.7 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 09 2018 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Grant | A | 3.10 | 3,145 | 9,750 | 504,749 | 501.6 K to 504.7 K (+0.63 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 | 74 M to 80 M (+8.11 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.90 | 571,164 | 1,087,553 | 73,978,672 | 73.4 M to 74 M (+0.78 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 59.82 | 12,634 | 755,708 | 9,681,129 | 9.7 M to 9.7 M (+0.13 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 59.76 | 17,248 | 1,030,813 | 9,668,495 | 9.7 M to 9.7 M (+0.18 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 59.15 | 1,600 | 94,634 | 9,651,247 | 9.6 M to 9.7 M (+0.02 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 58.28 | 30,321 | 1,767,153 | 9,649,647 | 9.6 M to 9.6 M (+0.32 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 57.34 | 17,859 | 1,024,114 | 9,619,326 | 9.6 M to 9.6 M (+0.19 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 56.66 | 4,080 | 231,174 | 9,601,467 | 9.6 M to 9.6 M (+0.04 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 55.01 | 6,399 | 352,005 | 9,597,387 | 9.6 M to 9.6 M (+0.07 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 54.32 | 26,304 | 1,428,875 | 9,590,988 | 9.6 M to 9.6 M (+0.28 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 2,724,202 | 0 | 0 | |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 339 | 0 | 1,015 | 676 to 1 K (+50.15 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 339 | 0 | 1,015 | 676 to 1 K (+50.15 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 676 | 0 | 676 | 0 to 676 |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 676 | 0 | 676 | 0 to 676 |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 13,621 | 0 | 0 | 13.6 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 13,621 | 0 | 13,621 | 0 to 13.6 K |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 27,242 | 0 | 0 | 27.2 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 27,242 | 0 | 27,242 | 0 to 27.2 K |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 2,724,202 | 0 | 0 | 2.7 M to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 2,724,202 | 0 | 2,724,202 | 0 to 2.7 M |
Jan 26 2018 | MIRN | SYNLOGIC, INC. | BARRETT M JAMES | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
Jan 04 2018 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Grant | A | 2.66 | 3,665 | 9,749 | 501,604 | 497.9 K to 501.6 K (+0.74 %) |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 5.00 | 2,000,000 | 10,000,000 | 5,554,610 | 3.6 M to 5.6 M (+56.26 %) |
Nov 27 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 569,620 | 0 | 2,724,202 | |
Nov 27 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Sell | S | 19.49 | 569,620 | 11,101,894 | 0 | 569.6 K to 0 (-100.00 %) |
Nov 27 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 569,620 | 0 | 569,620 | 0 to 569.6 K |
Nov 21 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 2,820,516 | 0 | 3,293,822 | |
Nov 21 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Sell | S | 19.49 | 2,820,516 | 54,971,857 | 0 | 2.8 M to 0 (-100.00 %) |
Nov 21 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 2,820,516 | 0 | 2,820,516 | 0 to 2.8 M |
Nov 08 2017 | CRCM | Care.com Inc | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 252 | 0 | 252 | 0 to 252 |
Nov 08 2017 | CRCM | Care.com Inc | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 252 | 0 | 252 | 0 to 252 |
Nov 08 2017 | CRCM | Care.com Inc | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Nov 08 2017 | CRCM | Care.com Inc | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Nov 08 2017 | CRCM | Care.com Inc | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,256,013 | 3.3 M to 2.3 M (-30.71 %) |
Oct 16 2017 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Grant | A | 0.00 | 3,250 | 0 | 497,939 | 494.7 K to 497.9 K (+0.66 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 2,927,708 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 1,402,870 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | BARRETT M JAMES | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 4,909,956 | 4.4 M to 4.9 M (+12.61 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 2,927,708 | 0 | 4,359,956 | 1.4 M to 4.4 M (+204.41 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 1,402,870 | 0 | 1,432,248 | 29.4 K to 1.4 M (+4,775.24 %) |
Aug 30 2017 | MIRN | SYNLOGIC, INC. | BARRETT M JAMES | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 2,216,626 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 18,001,419 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 11,931,173 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 | 7.1 M to 8.1 M (+14.01 %) |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 7,140,138 | 0 | 7,140,138 | 0 to 7.1 M |
Jun 30 2017 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 08 2017 | CLVS | Clovis Oncology, I ... | BARRETT M JAMES | Director | Option Exercise | A | 59.56 | 10,000 | 595,600 | 10,000 | |
Jun 05 2017 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Buy | P | 1.41 | 7,092,198 | 9,999,999 | 21,911,183 | 14.8 M to 21.9 M (+47.86 %) |
May 31 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 6,114,338 | |
May 31 2017 | APPN | APPIAN CORP | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 0 | |
May 30 2017 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | A | 13.89 | 11,000 | 152,790 | 11,000 | |
May 26 2017 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Option Exercise | A | 1.35 | 128,817 | 173,903 | 128,817 | |
Mar 28 2017 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 | 59.3 M to 72.1 M (+21.71 %) |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | J | 0.00 | 12,679,970 | 0 | 12,679,970 | |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 605,668 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 2,064,048 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 8,000,038 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 1,689,436 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 12,359,190 | 0 | 12,679,970 | 320.8 K to 12.7 M (+3,852.86 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 20 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 0.75 | 7,471 | 5,603 | 2,052,805 | 2.1 M to 2.1 M (-0.36 %) |
Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 13.00 | 461,538 | 5,999,994 | 3,554,610 | 3.1 M to 3.6 M (+14.92 %) |
Sep 15 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 0.74 | 10,000 | 7,400 | 2,060,276 | 2.1 M to 2.1 M (-0.48 %) |
Aug 31 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.01 | 50,000 | 50,440 | 2,070,276 | 2.1 M to 2.1 M (-2.36 %) |
Aug 26 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.21 | 1,200 | 1,452 | 2,120,276 | 2.1 M to 2.1 M (-0.06 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.33 | 8,989 | 11,957 | 2,121,476 | 2.1 M to 2.1 M (-0.42 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.33 | 8,989 | 11,957 | 2,121,476 | 2.1 M to 2.1 M (-0.42 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.24 | 14,158 | 17,550 | 2,130,465 | 2.1 M to 2.1 M (-0.66 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.24 | 14,158 | 17,550 | 2,130,465 | 2.1 M to 2.1 M (-0.66 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.17 | 534 | 625 | 2,144,623 | 2.1 M to 2.1 M (-0.02 %) |
Jul 21 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.17 | 534 | 625 | 2,144,623 | 2.1 M to 2.1 M (-0.02 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | BARRETT M JAMES | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 8,752,543 | 8 M to 8.8 M (+9.56 %) |
Jul 15 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.20 | 13,382 | 16,060 | 2,145,157 | 2.2 M to 2.1 M (-0.62 %) |
Jun 24 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 13 2016 | CLVS | Clovis Oncology, I ... | BARRETT M JAMES | Director | Option Exercise | A | 15.23 | 10,000 | 152,300 | 10,000 | |
May 26 2016 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Option Exercise | A | 3.43 | 54,629 | 187,377 | 54,629 | |
May 19 2016 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | A | 6.35 | 11,000 | 69,850 | 11,000 | |
Mar 18 2016 | TSRO | TESARO, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 35.19 | 710,429 | 24,999,997 | 9,564,684 | 8.9 M to 9.6 M (+8.02 %) |
Mar 23 2016 | SENS | Senseonics Holding ... | BARRETT M JAMES | Director | Buy | P | 2.85 | 1,578,947 | 4,499,999 | 14,818,985 | 13.2 M to 14.8 M (+11.93 %) |
Mar 24 2016 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Gift | G | 0.00 | 18,000 | 0 | 97,355 | 115.4 K to 97.4 K (-15.60 %) |
Mar 03 2016 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Option Exercise | A | 12.98 | 15,000 | 194,700 | 15,000 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 4,423,723 | 0 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 13,848,000 | 0 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 8.00 | 900,324 | 7,202,592 | 3,093,072 | 2.2 M to 3.1 M (+41.06 %) |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | C | 0.00 | 2,192,748 | 0 | 2,192,748 | 0 to 2.2 M |
Feb 12 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 8.00 | 45,760 | 366,080 | 45,760 | |
Jan 14 2016 | ARDX | ARDELYX, INC. | BARRETT M JAMES | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 7,988,893 | 7.5 M to 8 M (+6.68 %) |
Jan 12 2016 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.75 | 70,913 | 1,045,953 | 0 | 70.9 K to 0 (-100.00 %) |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.38 | 71,067 | 1,022,192 | 70,913 | 142 K to 70.9 K (-50.05 %) |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.54 | 70,990 | 1,032,152 | 141,980 | 213 K to 142 K (-33.33 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 212,970 | 0 | 212,970 | 0 to 213 K |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 8,733 | 0 | 24,317 | 15.6 K to 24.3 K (+56.04 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 11,980 | 0 | 33,360 | 21.4 K to 33.4 K (+56.03 %) |